Isolation of six new chrolactomycins shows antibacterial and cytotoxic properties, indicating potential for cancer treatment.
Six new spirotetronate polyketides, chrolactomycins A-F (2-7), and the known chrolactomycin (1) were isolated and identified from Catenulispora acidiphila TX15. Chrolactomycins D-F (5-7) feature an unprecedented dimeric skeleton bridged by a rare barbiturate unit. Sequencing and characterization of a type I polyketide synthase biosynthetic gene cluster led to the proposal of a biosynthetic pathway for 1-7. Compounds 2-4 exhibited antibacterial activities, while 3-7 displayed cytotoxicity to multiple cancer cell lines, with dimer 5 demonstrating the most potent effects (IC50 = 2.2-7.7 μM).
No takes yet. Share an insight, caveat, or question.
Hao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: